Výsledky vyhledávání - "İnci Şule Özer"

Akademický článek

Early Seizures in Patients with Acute Ischemic Stroke: Incidence, Predictive Factors, and Clinical Outcome

Autor: Seyda ERDOĞAN, Mine Hayriye SORGUN, Zeynep KUZU, Rezzak YILMAZ, Müge KUZU, Çağrı ULUKAN, Hafize ÇOTUR LEVENT, İnci Şule ÖZER, Sabiha TEZCAN, Sefer RZAYEV, Volkan YILMAZ, Canan TOGAY IŞIKAY

Publikováno v: Archives of Epilepsy, Vol 24, Iss 2, Pp 69-74 (2018)

Objectives:Cerebrovascular disease is one of the major causes of epileptic seizures in the elderly. The aim of this study was to identify the incidence and predictive factors of early seizures after ischemic stroke (ESAIS) and the effect of early sei

Externí odkaz: https://doaj.org/article/4cdb498a6cb54d69b953ee444453bb9a

Zobrazit plný text záznamu

Akademický článek

Etiologic Subtypes, Risk Factors, and Outcomes of Acute Ischemic Stroke in Young Patients

Autor: İnci Şule Özer, Mine Hayriye Sorgun, Sefer Rzayev

Publikováno v: Türk Nöroloji Dergisi, Vol 21, Iss 4, Pp 159-164 (2015)

Objective: Stroke in people aged less than 45 years is less frequent than in older patients, but has major impacts on both the individual and society. The aim of this study was to determine the etiologic subtypes of acute ischemic stroke in the youn

Externí odkaz: https://doaj.org/article/3d7ccb4ce1bc4818a9c4354c485770e5

Zobrazit plný text záznamu

Akademický článek

Switch from Immediate-release Pramipexole to Extended-release Pramipexole: The Safety and Efficacy Characteristics of Sixty-eight Patients

Autor: Müge Kuzu, İnci Şule Özer, Oğuzhan Herdi, Sabiha Tezcan, Muhittin Cenk Akbostancı

Publikováno v: Türk Nöroloji Dergisi, Vol 22, Iss 3, Pp 114-116 (2016)

Objective: To evaluate the safety and efficacy of switching from immediate-release pramipexole (pex) to extended-release pramipexole (pex-ER). Materials and Methods: Pex-ER became available in Turkey about a year ago, since then we documented satisf

Externí odkaz: https://doaj.org/article/12d324a56bc44ee1b19e96f36e80c108

Zobrazit plný text záznamu

How do hypertriglyceridemia and hypotriglyceridemia affect prognosis in acute ischemic stroke and what is their prevalence?

Autor: Zeynep Ziroğlu, Mine Hayriye Sorgun, Elif Fatma Taban, Sabiha Tezcan Aydemir, Hafize Çotur Levent, Çağrı Ulukan, Sefer Rzayev, Müge Kuzu Kumcu, Volkan Yılmaz, İnci Şule Özer, Anwar Rawandi, Canan Togay Işıkay

Publikováno v: Türk Beyin Damar Hastalıkları Dergisi, Vol 27, Iss 3, Pp 191-199 (2021)

INTRODUCTION: Many studies are examining the relationship between cardiovascular diseases and triglyceride levels, and it has been shown that hypertriglyceridemia significantly increases the risk independently. In this study, we wanted to investigate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92b31f46e24638dbbe38d7933c69c6bd
https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tbdhd&un=TBDHD-23590

Zobrazit plný text záznamu

Etiology and risk factors in the young patients with ischemic stroke

Autor: Sabiha Tezcan Aydemir, Müge Kuzu Kumcu, Canan Togay Işıkay, Sefer Rzayev, Hafize Çotur, Volkan Yilmaz, Mine Hayriye Sorgun, İnci Şule Özer, Anwar Rawandi, Çağrı Ulukan

Publikováno v: Türk Beyin Damar Hastalıkları Dergisi, Vol 26, Iss 1, Pp 126-131 (2020)

INTRODUCTION[|]Despite the lower frequency in the young than the older population, ischemic stroke has a significant impact on the patients and their families, and the society. In this study, ischemic stroke patients under the age of 50 years registe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f606ea726d65033628a8b34bacbe0189
https://www.journalagent.com/z4/download_fulltext.asp?pdir=tbdhd&un=TBDHD-70298

Zobrazit plný text záznamu

Dose conversion ratio, comparative efficacy, and adverse events after switching from onabotulinum toxin A to abobotulinum toxin A for neurological conditions

Autor: Müge Kuzu Kumcu, İnci Şule Özer, Muhittin Cenk Akbostanci, Sabiha Tezcan Aydemir

Publikováno v: Clinical neurology and neurosurgery. 209

Onabotulinum toxin A (ONA, Botox®) and abobotulinum toxin A (ABO, Dysport®) are most frequently used in the treatment of movement disorders. The aim of this study was to identify the dose conversion ratio (ABO dose:ONA dose), comparative efficacy,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::575f7df5f442e75d98b0291775977db5
https://pubmed.ncbi.nlm.nih.gov/34461363

Zobrazit plný text záznamu